Civitas Therapeutics, Inc. — Form D
Civitas Therapeutics, Inc. of CHELSEA, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-17. The offering totals $38.3M, of which $38.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-09-17
- Form: D
- Accession: 0001509697-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $38.3M
- Amount sold: $38.3M
- Investors: 11
- Date of first sale: 2013-09-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-203012
Issuer
- Name: Civitas Therapeutics, Inc.
- CIK: 0001509697
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 190 EVERETT AVENUE, CHELSEA, MA, 02150
- Phone: 617-660-4110
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Robert P Hopfner | Director | Chelsea, MA |
| Robert P Roche, Jr. | Director | Chelsea, MA |
| Rajeev P Shah | Director | Chelsea, MA |
| Timothy Shannon | Director | Stamford, CT |
| Glenn Batchelder | Executive Officer | Corcord, NH |
| Rob Hopfner | Director | San Diego, CA |
| Mark Iwicki | Director | Arlington, MA |
| Mark Iwicki | Executive Officer | Arlington, MA |
| RICHARD BATYCKY | Executive Officer | FRAMINGHAM, MA |
| David Hirsch | Director | San Diego, CA |
| MARTIN FREED | Executive Officer | WALTHAM, MA |
| Glenn Batchelder | Director | Corcord, NH |
| Andrea Franz | Executive Officer | Concord, NH |
| Bryan Stuart | Executive Officer | Cambridge, MA |
| Aidan King | Director | Dublin, L2 |
| Mary Taylor | Executive Officer | Needham, MA |
| BLAIR JACKSON | Director | CHELSEA, MA |
| TIMOTHY S NELSON | Director | CHELSEA, MA |
| RAJEEV S SHAH | Director | CHELSEA, MA |
| TIM S SHANNON | Director | CHELSEA, MA |
| ROBERT S ROCHE | Director | CHELSEA, MA |
Other filings by this issuer (3)
More